CIBC Private Wealth Group
SION

CIBC Private Wealth Group’s Sionna Therapeutics SION Stock Holding History

CIBC Private Wealth Group’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$185K Buy
+4,500
New +$171K ﹤0.01% 1227

Other funds holding SION

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CIBC Private Wealth Group's SION Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Sionna Therapeutics (SION) in Q4 2025: 4,500 shares worth $185K. The stake represents ﹤0.01% of the portfolio and ranks #1227 among its holdings.

101 funds tracked by Wall St. Rank hold SION as of Q4 2025.

  • CIBC Private Wealth Group held 4,500 shares of Sionna Therapeutics worth $185K as of Q4 2025.
  • Sionna Therapeutics was a new CIBC Private Wealth Group position in Q4 2025.
  • Sionna Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1227 holding.
  • 101 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.